Furthermore, studies have shown that CyPA knockout mice demonstrated a remarkable reduction in atherosclerosis and that CyPA was atherogenic by enhancing LDL uptake, adhesion molecule expression, and inflammatory cell migration, suggesting that CyPA is a potential target for cardiovascular therapies [13]. Here, PPIA is linked to atherosclerosis.